A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns

In a retrospective analysis of 457 Mayo Clinic patients (median age 72 years) with chronic myelomonocytic leukemia (CMML; proliferative 38%; CMML-2 15%), overall survival (OS), calculated from time of diagnosis, was not differentially affected by treatment exposure to i) neither cytotoxic nor non-c...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Muhammad Yousuf, Priyansh Faldu, Maymona Abdelmagid, Fnu Aperna, Saubia Fathima, Ali Khalid A. Alsugair, Clifford M. Csizmar, Terra L. Lasho, Abhishek A. Mangaonkar, Kaaren K. Reichard, Rong He, Animesh Pardanani, Naseema Gangat, Mrinal M. Patnaik., Ayalew Tefferi
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Ferrata Storti Foundation 2025-10-01
Sarja:	Haematologica
Linkit:	https://haematologica.org/article/view/12942
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!